People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Manufacturing, Other, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amyris, Inc. | — | Manufacturing | Series D+ | $1.6B | $77.1M | 2008 |
| Elevance Renewable Sciences, Inc. | — | Manufacturing | Series D+ | $319.9M | $208.4M | 2010 |
| Anuvia Plant Nutrients Holdings Inc. | — | Other | Series C | $195.3M | $802.9M | 2019 |
| Moksha8 Inc | — | Other Health Care | Series C | $93.5M | $1.4B | 2009 |
| Dnanexus, Inc. | — | Biotechnology | Series A | $31.6M | $542.3M | 2013 |
Geoff Duyk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geoff Duyk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carole Piwnica | 2 | 2 |
| Fernando Reinach | 2 | 2 |
| Samir Kaul | 1 | 32 |
| JOHN DOERR | 1 | 14 |
| Robert Shapiro | 1 | 13 |
| Michael Goldberg | 1 | 11 |
| ROB HAYES | 1 | 9 |
| CHRIS LARSON | 1 | 6 |
| Krishna Yeshwant | 1 | 5 |
| Mark Gudiksen | 1 | 5 |
| Patrick Kelly | 1 | 4 |
| Amy Yoder | 1 | 4 |
| Neil Renninger | 1 | 4 |
| L. John Doerr | 1 | 4 |
| Stephen Thau | 1 | 4 |
| STEVEN MILLS | 1 | 3 |
| Philippe Boisseau | 1 | 3 |
| John Melo | 1 | 3 |
| Richard Daly | 1 | 3 |
| Patrick Pichette | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.